Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Recenti Progressi in Medicina|November 1, 1992
A case of vascular purpura with scurvyA Salvi, A Coppini, G Lazzaroni, et al.
Recenti Progressi in Medicina|February 1, 1992
Primary empty sella syndrome and hypogonadotropic hypogonadism in young male patientsR Candrina, T Scalvini, A Coppini, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
Systolic hypertension in the elderly: long-term lacidipine treatment. Objective, protocol, and organization. SHELL Study GroupE Malacco, A E Gnemmi, A Romagnoli, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Assessment of the biological activity of synthetic salmon calcitonin by intranasal administration in healthy volunteersC E Fiore, A Romagnoli, R Foti, et al.
Acta Diabetologica|August 7, 1999
A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patientsG Erle, S Lovise, C Stocchiero, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Human pharmacokinetics of glycosaminoglycans using deuterium-labeled and unlabeled substances: evidence for oral absorptionL Silvestro, E Lanzarotti, E Marchi, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Humoral and haemodynamic effects of idrapril calcium, the prototype of a new class of ACE-inhibitors, in essential hypertensive patientsS Taddei, L Ghiadoni, P Mattei, et al.
Chempluschem|June 26, 2024
Total Synthesis of an Epothilone Analogue Based on the Amide-Triazole BioisosterismEleonora Colombo, Davide A Coppini, Simone Borsoi, et al.
Rheumatology (Oxford, England)|March 27, 2007
Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot studyG Saviola, L Abdi Ali, S Shams Eddin, et al.
Clinical and Experimental Rheumatology|July 10, 2002
Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot studyG Saviola, L Abdi Ali, P Rossini, et al.
Pageof 2